Clinical Trials
4 trialsNCT04841811 2026-05-22
APPROACH
Guangdong Association of Clinical Trials
Phase 3 Active not recruiting
NCT06300424 2026-04-29
NEOVADE
Guangdong Provincial People's Hospital
Phase 2 Active not recruiting
NCT06613633 2026-04-29
Third-generation EGFR-TKI Treatment in Metastatic EGFR-mutant NSCLC
Fudan University
Completed
NCT06951464 2025-07-23
A Study of BL-B01D1 and Almonertinib in Patients With Resectable EGFR+ Stage II-IIIB NSCLC
Sichuan University
Phase 2 Recruiting